Our Editorial Policy
Peptides fall squarely into what Google calls YMYL, “your money or your life,” because bad information here can cost people real money and real health. We take that seriously. This KlowStackPeptide policy lays out exactly how we research, write, review, and correct our guides, so you can judge our work by its process and not just its polish.
What We Promise You
Four commitments anchor everything we publish, and we hold ourselves to all four.
- Accuracy. Every factual claim traces to a source we have read and checked.
- Clarity. We translate the science into plain English without bending what it says.
- Independence. Our conclusions come from the evidence, and no company can buy a better one.
- Humility. When the research is thin or unsettled, we say so plainly instead of guessing.
Read more About Us.
How a Guide Gets Made
Nothing goes live on a whim. Each guide moves through the same five steps before it reaches you.
- Research. A writer gathers primary sources, PubMed, ClinicalTrials.gov, peer-reviewed journals, and regulator pages, and reads the original work.
- Draft. A writer with a biomedical background turns that reading into a clear guide, citing sources as they go.
- Review. Someone with clinical or chemistry training checks the draft for accuracy, fair interpretation, and sound use of the sources.
- Fact-check. A second pass verifies the numbers, the citations, and every outbound link.
- Publish and revisit. The guide goes up with a visible date, and we come back to update it as new research lands.
The Sources We Trust, and the Ones We Skip
Not all evidence carries the same weight, so we grade it on a simple ladder and tell you where a claim falls.
| Tier | What it includes | How we treat it |
|---|---|---|
| Strong | Meta-analyses, systematic reviews, well-run human trials, WHO/FDA/EMA guidance | Stated as solid, with the source linked |
| Moderate | Animal studies, large observational studies, early-phase trials | Reported as promising but limited |
| Early | Cell studies, single case reports, expert commentary | Labeled as preliminary, treated with care |
We leave out marketing pages, anonymous blogs, lone testimonials, and predatory journals. And we never dress up an animal or cell result as proof of a human effect, because that swap is where most peptide hype begins.
How We Label What We Know
A big part of trust is being clear about your level of certainty, so we sort every claim into one of four buckets and write it accordingly.
- Settled science: backed by strong evidence and stated with confidence.
- Emerging research: written with careful language like “early data suggests.”
- Open questions: flagged as unproven ideas that still need testing.
- Our opinion: clearly marked as editorial judgment, kept separate from the facts.
You will always be able to tell which is which. When the real answer is “we do not know yet,” that is the answer you will get.
Staying Independent
Our read on a compound is worth something only if it is truly our own, so we protect that hard. Peptide sellers and supplement companies do not sponsor our articles, and no advertiser gets a say in what we conclude. Our editorial team and our business side are kept apart, so the people writing the guides answer to the evidence alone.
Some pages carry affiliate links, and we disclose them clearly. Those links help fund the work, but they never change a verdict. If a widely sold stack is under-studied, we say so, even when a link on the page points to a seller.
How We Use AI
We use AI tools the way a good newsroom uses a research assistant: to help gather sources, draft outlines, and catch typos. Every guide is then researched, checked, and signed off by real people with the training to judge the science.
A human decides what we publish and stands behind it. AI never has the final word on a health-adjacent page, and it never invents a source, a statistic, or a study on our site.
When We Get It Wrong
We will make mistakes, and how we handle them is part of the policy.
- Clear factual errors get corrected quickly, with a note explaining what changed and when.
- Small fixes, like a typo or an awkward line, are corrected directly.
- Serious errors send a guide back for a full rewrite, and we tell readers while that happens.
If you spot something wrong, tell us. A reader who catches an error is doing us a favor, and we treat it that way.
Keeping Guides Current
Peptide science is progressing fast, and a guide that was accurate last year can drift out of date. We revisit our pages on a regular cycle and whenever a major study or regulatory update lands, then adjust the conclusions to match. The date on each guide shows when we last touched it.
Reach the Editors
We welcome a note whether you have found an error, want to suggest a topic, have a question about these standards, or are a qualified professional who would like to review our work. Use the contact page and we will get back to you.
For how these standards apply to your own use of the site, see our medical disclaimer.